The form was uploaded to medical-data-models.org - Original URL: https://medical-data-models.org/16420
StudyName: Eligibility Breast Cancer NCT00591851
Date of export from the portal: 02.07.2020
Date of Upload / last change: 15.07.2016
License: Creative Commons BY 4.0

----

Description: 
Phase II Study of Dose-Dense Doxurubicin and Cyclophosphamide (AC) Followed By Paclitaxel With Trastuzumab in HER2/ NEU-Amplified Breast Cancer: Feasibility; ODM derived from: https://clinicaltrials.gov/show/NCT00591851
